DE2607106C2 - 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung - Google Patents

2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Info

Publication number
DE2607106C2
DE2607106C2 DE2607106A DE2607106A DE2607106C2 DE 2607106 C2 DE2607106 C2 DE 2607106C2 DE 2607106 A DE2607106 A DE 2607106A DE 2607106 A DE2607106 A DE 2607106A DE 2607106 C2 DE2607106 C2 DE 2607106C2
Authority
DE
Germany
Prior art keywords
dioxatricyclo
decane
methoxy
hydroxy
deep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2607106A
Other languages
German (de)
English (en)
Other versions
DE2607106A1 (de
Inventor
Akiji Dipl.-Chem. 3015 Wennigsen Asai
Samuel Dr. 3000 Hannover David
Peter Willibrord Dr. 3000 Hannover Thies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Priority to DE2607106A priority Critical patent/DE2607106C2/de
Priority to DE19762661027 priority patent/DE2661027C2/de
Priority to CH1977A priority patent/CH638211A5/de
Priority to MX775343U priority patent/MX5194E/es
Priority to FI770316A priority patent/FI770316A/fi
Priority to NL7701091A priority patent/NL7701091A/xx
Priority to GB5223/77A priority patent/GB1579081A/en
Priority to HU77KA1483A priority patent/HU178020B/hu
Priority to NZ183327A priority patent/NZ183327A/xx
Priority to HU7781751A priority patent/HU178905B/hu
Priority to IL51441A priority patent/IL51441A/xx
Priority to ZA00770847A priority patent/ZA77847B/xx
Priority to IE321/77A priority patent/IE44774B1/en
Priority to ES455940A priority patent/ES455940A1/es
Priority to AU22339/77A priority patent/AU512172B2/en
Priority to FR7704353A priority patent/FR2341581A1/fr
Priority to SE7701778A priority patent/SE432765B/xx
Priority to US05/770,055 priority patent/US4163055A/en
Priority to PT66206A priority patent/PT66206B/pt
Priority to AT112277A priority patent/AT357550B/de
Priority to NO770545A priority patent/NO147341C/no
Priority to DD7700197442A priority patent/DD128736A5/xx
Priority to DK73077A priority patent/DK73077A/da
Priority to PL1977196122A priority patent/PL115308B1/pl
Priority to GR52811A priority patent/GR62077B/el
Priority to BE6045892A priority patent/BE851681A/xx
Priority to SU772455502A priority patent/SU791242A3/ru
Priority to CA272,194A priority patent/CA1098528A/en
Priority to JP1802677A priority patent/JPS52102299A/ja
Priority to PH19470A priority patent/PH16259A/en
Priority to YU00476/77A priority patent/YU47677A/xx
Priority to CS771138A priority patent/CS208651B2/cs
Publication of DE2607106A1 publication Critical patent/DE2607106A1/de
Priority to US05/897,802 priority patent/US4158061A/en
Priority to US05/904,742 priority patent/US4207331A/en
Priority to AT440579A priority patent/AT357556B/de
Priority to US06/075,706 priority patent/US4242341A/en
Priority to CH107381A priority patent/CH638526A5/de
Priority to NO820154A priority patent/NO820154L/no
Application granted granted Critical
Publication of DE2607106C2 publication Critical patent/DE2607106C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE2607106A 1976-02-21 1976-02-21 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung Expired DE2607106C2 (de)

Priority Applications (38)

Application Number Priority Date Filing Date Title
DE2607106A DE2607106C2 (de) 1976-02-21 1976-02-21 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung
DE19762661027 DE2661027C2 (US20110158925A1-20110630-C00042.png) 1976-02-21 1976-02-21
CH1977A CH638211A5 (de) 1976-02-21 1977-01-03 Verfahren zur herstellung neuer 2,9-dioxatricyclodecane.
MX775343U MX5194E (es) 1976-02-21 1977-01-14 Procedimiento para preparar 3-aminometi-4-beta-hidroxi-8-beta-alcoxi-2,9-dioxatriciclo(4,3,1,03,7)decano
FI770316A FI770316A (US20110158925A1-20110630-C00042.png) 1976-02-21 1977-01-31
NL7701091A NL7701091A (nl) 1976-02-21 1977-02-02 2,9-dioxatricyclo (4,3,1,03'7) decanen en werkwijze voor de bereiding daarvan.
GB5223/77A GB1579081A (en) 1976-02-21 1977-02-08 2,9-dioxatricyclo(4,3,1,0) decanes and a method of producing the same
HU77KA1483A HU178020B (en) 1976-02-21 1977-02-14 Process for producing 2,9-dioxatricyclo-square bracket-4,3,1,o-3,7-above-square bracket closed-decanes
NZ183327A NZ183327A (en) 1976-02-21 1977-02-14 2,9-dioxatricyclo(4,3,1,03,1)decanes
HU7781751A HU178905B (en) 1976-02-21 1977-02-14 Process for preparing new 3-amino-methyl-4beta-hydroxy-2,9-dioxatricyclo/4,3,10 up 3,7 /decanes
IL51441A IL51441A (en) 1976-02-21 1977-02-14 3-aminomethyl-2,9-dioxatricyclo(4,3,1,33.7)decane derivatives and their production
ZA00770847A ZA77847B (en) 1976-02-21 1977-02-14 2,9-dioxatricyclo(4,3,1,03,7)decanes and method of producing same
IE321/77A IE44774B1 (en) 1976-02-21 1977-02-15 2,9-dioxatricyclo (4.3.1.03,7) decanes and a method of producing the same
ES455940A ES455940A1 (es) 1976-02-21 1977-02-16 Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7) decanos.
AU22339/77A AU512172B2 (en) 1976-02-21 1977-02-16 2, 9-dioxatricylclo (4, 3, 1, 03, 7 ) decanes
FR7704353A FR2341581A1 (fr) 1976-02-21 1977-02-16 2,9-dioxatricyclo(4,3,1,03,7) decanes et procede pour leur preparation
SE7701778A SE432765B (sv) 1976-02-21 1977-02-17 Forfarande for framstellning av 2,9-dioxatricyklo/4,3,1,0?723?72,?727/dekaner
PT66206A PT66206B (en) 1976-02-21 1977-02-18 Process for preparing 2,9-dioxatricyclo/4,3,1,03,7/decanes
US05/770,055 US4163055A (en) 1976-02-21 1977-02-18 2,9-Dioxatricyclo[4,3,1,03,7 ] decane derivatives and pharmaceutical compositions thereof
AT112277A AT357550B (de) 1976-02-21 1977-02-18 Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen
NO770545A NO147341C (no) 1976-02-21 1977-02-18 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2,9-dioxatricyclo-(4.3.1.03,7)-decaner
DD7700197442A DD128736A5 (de) 1976-02-21 1977-02-18 Verfahren zur herstellung von 2,9-dioxatricyclo eckige klammer auf 4,3,1,0 hoch 3,hoch 7 eckige klammer zu decanen
DK73077A DK73077A (da) 1976-02-21 1977-02-18 Fremgangsmade til fremstilling af 2,9-dioxatricyclo (4,3,1,03,7) decaner
GR52811A GR62077B (en) 1976-02-21 1977-02-19 Preparation process of 2,9-dioxatricyclo(4,3,1,03,7)decans
PL1977196122A PL115308B1 (en) 1976-02-21 1977-02-19 Process for preparing novel 2,9-dioxatncyclo-/4,3,1,0,3,7/decanes
SU772455502A SU791242A3 (ru) 1976-02-21 1977-02-21 Способ получени производных 2,9-диоксатрицикло (4,3,1,0 )декана или их солей
CA272,194A CA1098528A (en) 1976-02-21 1977-02-21 New 2,9-dioxatricyclo[4,3,1,0 su3,7 xx] decane derivatives, process for their preparation and pharmaceutical compositions thereof
JP1802677A JPS52102299A (en) 1976-02-21 1977-02-21 2*99dioxatricyclo*4*3*1*03*7*decane and process for preparing same
PH19470A PH16259A (en) 1976-02-21 1977-02-21 2,9-dioxatricyclo(4,3,1,0 3,7)decane and a method of producing the same
BE6045892A BE851681A (fr) 1976-02-21 1977-02-21 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
YU00476/77A YU47677A (en) 1976-02-21 1977-02-21 Process for preparing dioxatricyclo^4,3,1,0,7[decanes
CS771138A CS208651B2 (en) 1976-02-21 1977-02-21 Method of making the 2,9-dioxatricaclo/4,3,1,03,7 decanes
US05/897,802 US4158061A (en) 1976-02-21 1978-04-19 2,9-Dioxatricyclo[4,3,1,03,7 ] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
US05/904,742 US4207331A (en) 1976-02-21 1978-05-11 2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives and pharmaceutical compositions thereof
AT440579A AT357556B (de) 1976-02-21 1979-06-22 Verfahren zur herstellung von neuen 3-amino- methyl-4beta-hydroxy-2,9-dioxatricyclo(4,3,1, 03,7)decanen und deren salzen
US06/075,706 US4242341A (en) 1976-02-21 1979-09-14 2,9-Dioxatricyclo [4,3,1,03,7 ] decane derivatives and pharmaceutical compositions
CH107381A CH638526A5 (de) 1976-02-21 1981-02-18 Verfahren zur herstellung neuer 2,9-dioxatricyclo-decane.
NO820154A NO820154L (no) 1976-02-21 1982-01-19 Fremgangsmaate ved fremstilling av 3-aminomethyl-4beta-hydroxy-2,9-dioxatricyclo(4,3,1,03,7)-decaner.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2607106A DE2607106C2 (de) 1976-02-21 1976-02-21 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Publications (2)

Publication Number Publication Date
DE2607106A1 DE2607106A1 (de) 1977-09-01
DE2607106C2 true DE2607106C2 (de) 1986-01-16

Family

ID=5970538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2607106A Expired DE2607106C2 (de) 1976-02-21 1976-02-21 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Country Status (30)

Country Link
US (2) US4163055A (US20110158925A1-20110630-C00042.png)
JP (1) JPS52102299A (US20110158925A1-20110630-C00042.png)
AT (1) AT357550B (US20110158925A1-20110630-C00042.png)
AU (1) AU512172B2 (US20110158925A1-20110630-C00042.png)
BE (1) BE851681A (US20110158925A1-20110630-C00042.png)
CA (1) CA1098528A (US20110158925A1-20110630-C00042.png)
CH (2) CH638211A5 (US20110158925A1-20110630-C00042.png)
CS (1) CS208651B2 (US20110158925A1-20110630-C00042.png)
DD (1) DD128736A5 (US20110158925A1-20110630-C00042.png)
DE (1) DE2607106C2 (US20110158925A1-20110630-C00042.png)
DK (1) DK73077A (US20110158925A1-20110630-C00042.png)
ES (1) ES455940A1 (US20110158925A1-20110630-C00042.png)
FI (1) FI770316A (US20110158925A1-20110630-C00042.png)
FR (1) FR2341581A1 (US20110158925A1-20110630-C00042.png)
GB (1) GB1579081A (US20110158925A1-20110630-C00042.png)
GR (1) GR62077B (US20110158925A1-20110630-C00042.png)
HU (2) HU178905B (US20110158925A1-20110630-C00042.png)
IE (1) IE44774B1 (US20110158925A1-20110630-C00042.png)
IL (1) IL51441A (US20110158925A1-20110630-C00042.png)
MX (1) MX5194E (US20110158925A1-20110630-C00042.png)
NL (1) NL7701091A (US20110158925A1-20110630-C00042.png)
NO (2) NO147341C (US20110158925A1-20110630-C00042.png)
NZ (1) NZ183327A (US20110158925A1-20110630-C00042.png)
PH (1) PH16259A (US20110158925A1-20110630-C00042.png)
PL (1) PL115308B1 (US20110158925A1-20110630-C00042.png)
PT (1) PT66206B (US20110158925A1-20110630-C00042.png)
SE (1) SE432765B (US20110158925A1-20110630-C00042.png)
SU (1) SU791242A3 (US20110158925A1-20110630-C00042.png)
YU (1) YU47677A (US20110158925A1-20110630-C00042.png)
ZA (1) ZA77847B (US20110158925A1-20110630-C00042.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2730988A1 (de) 1977-07-08 1979-01-25 Kali Chemie Pharma Gmbh 3-azidomethyl-2,9-dioxatricyclo eckige klammer auf 4,3,1,0 hoch 3,7 eckige klammer zu decane und verfahren zu deren herstellung
FR2435476A1 (fr) * 1978-09-05 1980-04-04 Kali Chemie Pharma Gmbh Procede pour la preparation de 3-azidomethyl-2,9-dioxatricyclo(4,3,1,03,7) decanes
DE3026579A1 (de) * 1980-07-14 1982-02-11 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-dioxatricyclo (4,3,1,o(pfeil hoch)3,7(pfeil hoch)) decane
DE3335826A1 (de) * 1983-10-01 1985-04-18 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue n-(2,10-dioxa-tricyclo-(5,3,1,0(pfeil hoch)3(pfeil hoch)(pfeil hoch),(pfeil hoch)(pfeil hoch)8(pfeil hoch))- undecan-5-yl)-tryptamin-derivate
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US7226886B2 (en) * 2005-09-15 2007-06-05 Chevron Phillips Chemical Company, L.P. Polymerization catalysts and process for producing bimodal polymers in a single reactor
RU2494102C1 (ru) * 2012-08-15 2013-09-27 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ НАУКИ ИНСТИТУТ ОРГАНИЧЕСКОЙ ХИМИИ им. Н.Д. ЗЕЛИНСКОГО РОССИЙСКОЙ АКАДЕМИИ НАУК (ИОХ РАН) Способ получения замещенных 2,3,5,6-тетраоксабицикло[2.2.1]гептанов

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1961433C3 (de) 1969-12-08 1974-06-06 Kali Chemie Ag S-Alkoxy^-hydroxy-S-methyl-lOmethylen-2,9-dioxatricyclo-(4,3,l,0 hoch 3,hoch 7)-decane und 8-Alkoxy-4-hydroxy-3,10-dimethyl-2,9dioxatricyclo-(4,3,1,0 hoch 3Jioch 7)-decane sowie Verfahren zu ihrer Herstellung
DE2027890C3 (de) 1970-06-06 1979-02-01 Kali Chemie Ag 8-AIkoxy oder -Benzyloxy-3-methyl-lO- methylen-2,9-dioxatricyclo-(43,l,03,7 )-decan-4-one und 8-AIkoxy oder 8-Benzyloxy-3,10-dimethyl-2,9dioxatricyclo- (43,1,O" )-decan-4-one
DE2129507C3 (de) 1971-06-15 1980-02-14 Kali-Chemie Ag, 3000 Hannover Verfahren zur Herstellung von 8-Alkoxy-3halogenmethyl-4-acetoxy- 10-methylen-2,9dioxatricyclo(43,l,03 7 )decanen
DE2306118C3 (de) 1973-02-08 1980-10-16 Kali-Chemie Pharma Gmbh, 3000 Hannover S-Methyl-lO-methylen^-dioxatricyclo [43,1,037I decane und 3,10-Dimethyl2,9-dioxatricyclo [43,1, 03·7! decane sowie Verfahren zu deren Herstellung
DE2547205C2 (de) 1975-10-22 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812154A (en) * 1969-12-08 1974-05-21 Kali Chemie Ag Dioxatricyclodecanes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1961433C3 (de) 1969-12-08 1974-06-06 Kali Chemie Ag S-Alkoxy^-hydroxy-S-methyl-lOmethylen-2,9-dioxatricyclo-(4,3,l,0 hoch 3,hoch 7)-decane und 8-Alkoxy-4-hydroxy-3,10-dimethyl-2,9dioxatricyclo-(4,3,1,0 hoch 3Jioch 7)-decane sowie Verfahren zu ihrer Herstellung
DE2027890C3 (de) 1970-06-06 1979-02-01 Kali Chemie Ag 8-AIkoxy oder -Benzyloxy-3-methyl-lO- methylen-2,9-dioxatricyclo-(43,l,03,7 )-decan-4-one und 8-AIkoxy oder 8-Benzyloxy-3,10-dimethyl-2,9dioxatricyclo- (43,1,O" )-decan-4-one
DE2129507C3 (de) 1971-06-15 1980-02-14 Kali-Chemie Ag, 3000 Hannover Verfahren zur Herstellung von 8-Alkoxy-3halogenmethyl-4-acetoxy- 10-methylen-2,9dioxatricyclo(43,l,03 7 )decanen
DE2306118C3 (de) 1973-02-08 1980-10-16 Kali-Chemie Pharma Gmbh, 3000 Hannover S-Methyl-lO-methylen^-dioxatricyclo [43,1,037I decane und 3,10-Dimethyl2,9-dioxatricyclo [43,1, 03·7! decane sowie Verfahren zu deren Herstellung
DE2547205C2 (de) 1975-10-22 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
FR2341581B1 (US20110158925A1-20110630-C00042.png) 1980-10-31
DE2607106A1 (de) 1977-09-01
US4163055A (en) 1979-07-31
JPS52102299A (en) 1977-08-27
SE7701778L (sv) 1977-08-22
AU2233977A (en) 1978-08-24
SU791242A3 (ru) 1980-12-23
GR62077B (en) 1979-02-20
US4242341A (en) 1980-12-30
AU512172B2 (en) 1980-09-25
NO820154L (no) 1977-08-23
HU178020B (en) 1982-02-28
NO147341B (no) 1982-12-13
IL51441A (en) 1981-07-31
NL7701091A (nl) 1977-08-23
PT66206A (en) 1977-03-01
SE432765B (sv) 1984-04-16
YU47677A (en) 1982-06-30
CA1098528A (en) 1981-03-31
CH638211A5 (de) 1983-09-15
NO147341C (no) 1983-03-23
PL196122A1 (pl) 1978-04-24
CS208651B2 (en) 1981-09-15
IL51441A0 (en) 1977-04-29
ATA112277A (de) 1979-12-15
DD128736A5 (de) 1977-12-07
ZA77847B (en) 1978-09-27
IE44774L (en) 1977-08-21
AT357550B (de) 1980-07-10
PH16259A (en) 1983-08-19
JPS5748073B2 (US20110158925A1-20110630-C00042.png) 1982-10-14
PL115308B1 (en) 1981-03-31
FR2341581A1 (fr) 1977-09-16
BE851681A (fr) 1977-08-22
NO770545L (no) 1977-08-23
IE44774B1 (en) 1982-03-24
FI770316A (US20110158925A1-20110630-C00042.png) 1977-08-22
NZ183327A (en) 1979-03-28
CH638526A5 (de) 1983-09-30
PT66206B (en) 1978-08-12
ES455940A1 (es) 1978-03-01
MX5194E (es) 1983-04-22
DK73077A (da) 1977-08-22
GB1579081A (en) 1980-11-12
HU178905B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
DE2760372C2 (US20110158925A1-20110630-C00042.png)
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2345064C3 (de) 4-Amino-2-<l,2r3,4-tetrahydroisochinolin-2 yl)-chinazolinderivate und diese enthaltende Arzneimittel
WO2006018222A1 (de) Hydrate und polymorphe des 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamid, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE2540633A1 (de) Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE60123643T2 (de) Benzimidazolonderivate mit affinität zu serotonin- und dopaminrezeptoren
DE2607106C2 (de) 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung
DE2617738C2 (US20110158925A1-20110630-C00042.png)
DE3028001A1 (de) Neue, in 5-stellung substituierte 5,10-dihydro-11h-dibenzo (b,e)(1,4) diazepin-11-one, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
EP0233483B1 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
EP0213293B1 (de) In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0254955A2 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0312895A2 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0085892A1 (de) Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2420964A1 (de) Aminsubstituierte tetracyclische verbindungen
DE2724478A1 (de) Neue, in 11-stellung substituierte 5,11-dihydro-6h-pyrido eckige klammer auf 2,3-b eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2230154A1 (de) N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
DE1568104C3 (de) Tricyclische N-alkylierte Derivate des Acetamide und Verfahren zu ihrer Herstellung
EP0078949B1 (de) Neue 1-Furyl-3,4-dihydroisochinoline diese enthaltende Arzneimittel sowie Verfahren zu deren Herstellung und deren Verwendung
CH621341A5 (US20110158925A1-20110630-C00042.png)
EP0326066A2 (de) Neue kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE68903465T4 (de) Tricyclische Aromatasehemmer.
DE2333262A1 (de) Verfahren zur herstellung von neuen 1,1a,6,10b-tetrahydro-1,6-methano-dibenzo eckige klammer auf a,e eckige klammer zu -cyclopropa eckige klammer auf c eckige klammer zu cyclohepten-derivaten
DE2824291A1 (de) Neue benzylalkoholderivate und verfahren zu ihrer herstellung
DE2238941A1 (de) Verfahren zur herstellung von bestimmten indolbenzazepinderivaten

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
Q176 The application caused the suspense of an application

Ref document number: 2730988

Country of ref document: DE

Ref document number: 2719916

Country of ref document: DE

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2661027

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2661027

AG Has addition no.

Ref country code: DE

Ref document number: 2719916

Format of ref document f/p: P

D2 Grant after examination
8380 Miscellaneous part iii

Free format text: ES ERFOLGT NEUDRUCK DER FEHLERHAFT GEDRUCKTEN PATENTSCHRIFT

8364 No opposition during term of opposition
AG Has addition no.

Ref country code: DE

Ref document number: 2719916

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 2661027

Format of ref document f/p: P

8339 Ceased/non-payment of the annual fee